| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropyl methylcellulose 0.32% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose+phenylephrine 0.5/0.12% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropyl methylcellulose eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Product containing hypromellose and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypotonic artificial tears eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropyl methylcellulose 0.3% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropyl methylcellulose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose adverse reaction |
Causative agent (attribute) |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose eye drops adverse reaction |
Causative agent (attribute) |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Allergy to hypromellose |
Causative agent (attribute) |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose eye drops allergy |
Causative agent (attribute) |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Product containing hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hydroxypropyl methylcellulose 0.32% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose+phenylephrine 0.5/0.12% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypromellose 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropyl methylcellulose eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Product containing hypromellose and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Hydroxypropylmethylcellulose 1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropylmethylcellulose 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropylmethylcellulose in balanced salt solution 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hypotonic artificial tears eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropyl methylcellulose 0.3% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropylmethylcellulose 2% injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropylmethylcellulose 1.8% injection solution 1.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropyl methylcellulose 0.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropyl methylcellulose 2.5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Hydroxypropyl cellulose 5mg/unt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Product containing dextran 70 and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Dexamethasone+hypromellose 0.1%/0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
|
| Product containing glucose and glutathione and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Allergy to hypromellose |
Causative agent (attribute) |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose eye drops allergy |
Causative agent (attribute) |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Product containing hypromellose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Product containing hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hydroxypropyl methylcellulose 0.32% conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hydroxypropyl methylcellulose 0.32% conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose 3 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose 3 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose 10 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose 10 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose 5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose 5 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely dextran 70 1 milligram/1 milliliter and hypromellose 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Dextran 70- and hypromellose-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextran 70 and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Hypromellose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Glucose and glutathione and hypromellose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hypromellose and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Product containing only hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hypromellose in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dextran 70 and hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose 3.2 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Hypromellose 3.2 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dexamethasone and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Dexamethasone and hypromellose only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Product containing dexamethasone and hypromellose in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Product containing dexamethasone and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely hypromellose 3.2 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely hypromellose 3.2 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hypromellose (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]